Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 trial evaluating a self-assembled skin substitute for Epidermolysis Bullosa Dystrophica, with the study currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Self-Assembled Skin Substitute

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Epidermolysis Bullosa Dystrophica | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING